Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                OTP Events, Meetings, and Workshops

OTP Events, Meetings, and Workshops Home
          News & Events
          OTP Events, Meetings, and Workshops
          FDA CBER Webinar: Human Gene Therapy Products Incorporating Human Genome Editing - 02/29/2024OTP Events, Meetings, and Workshops Webcast
    Event Title
              FDA CBER Webinar: Human Gene Therapy Products Incorporating Human Genome Editing


                  February 29, 2024

  

    
  Share
    Post
    Linkedin

    Email
    PrintOn This Page
      Meeting InformationDate:
          
  


     
           

February 29, 2024   

 
 
        
                                      Time: 
                                      
1:00 PM
    - 2:00 PM
ET
                
  Organized By: 
      Organizer
          Center for Biologics Evaluation and Research

 

     Attend
    Register for This Event
  The FDA Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual public webinar on Thursday, February 29 at 1:00 pm to discuss a recently finalized guidance document on developing human gene therapy products that incorporate human genome editing. This guidance is intended to assist industry members and provide them with recommendations on what to include in an investigational new drug (IND) application, and how best to design, manufacture, and test these products.

FDA CBER Genome Editing Webinar Banner, Thursday, February 29, 2024 1-2pm ET


In this webinar, CBER subject matter experts will highlight key considerations in the final guidance. Registrants can submit questions in advance during the registration process.

Meeting Information and Registration

This event is free and open to the public. However, registration is required. Please see the link below to register.

Date: Thursday, February 29, 2024
	Time: 1:00 p.m. – 2:00 p.m. ET
	Location: The webinar will be held via Zoom.Please register for the webinar now. Please note, there will not be an option to ask live questions during this event. There will be an opportunity during registration to share a question with the speakers and panelists. **The deadline to submit questions via registration is February 13, 2024**. A recording and other relevant meeting materials will be posted online following the event.

*Please note, the FDA is not able to comment on or answer questions regarding specific investigational products or drug applications during this event. Further, questions considered inappropriate or out of scope for the event will not be addressed.*

About FDA CBER OTP

FDA CBER OTP oversees development for a wide variety of biological products, including gene and cell therapies, tissues and tissue engineering products, xenogeneic products, and more. OTP strives to lead all regulatory decisions with data, impartiality, and compassion and always welcomes the participation of patients and their advocates in formal meetings related to the development of investigational products. Learn more about OTP and view information on other meetings and workshops.

Stay Connected

Sign up for the CBER Listserv or follow us on social media to stay up to date on all FDA CBER news and events.

                                                                                  Content current as of:
      01/29/2024More Meetings,
      Conferences, and
      Workshops
        
        OTP Events, Meetings, and Workshops
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop